Name | Number of supported studies | Average coverage | |
---|---|---|---|
mast cell | 21 studies | 37% ± 12% | |
astrocyte | 10 studies | 33% ± 13% | |
fibroblast | 7 studies | 23% ± 8% | |
epithelial cell of proximal tubule | 5 studies | 24% ± 6% | |
smooth muscle cell | 5 studies | 27% ± 7% | |
hepatocyte | 5 studies | 55% ± 19% | |
GABAergic neuron | 4 studies | 27% ± 14% | |
enterocyte | 4 studies | 20% ± 4% | |
cardiac muscle cell | 4 studies | 23% ± 1% | |
ciliated cell | 4 studies | 22% ± 5% | |
adipocyte | 4 studies | 26% ± 3% | |
glutamatergic neuron | 4 studies | 46% ± 18% | |
pancreatic A cell | 3 studies | 20% ± 3% | |
neuron | 3 studies | 33% ± 14% | |
epithelial cell | 3 studies | 28% ± 10% | |
ependymal cell | 3 studies | 37% ± 17% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 29% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 99% | 9948.53 | 224 / 226 | 99% | 221.85 | 400 / 406 |
kidney | 100% | 4587.26 | 89 / 89 | 90% | 205.66 | 807 / 901 |
brain | 97% | 7072.05 | 2567 / 2642 | 79% | 194.79 | 557 / 705 |
prostate | 93% | 5489.99 | 228 / 245 | 82% | 92.91 | 410 / 502 |
breast | 99% | 5784.51 | 453 / 459 | 64% | 134.52 | 719 / 1118 |
adrenal gland | 98% | 5650.91 | 254 / 258 | 60% | 53.86 | 137 / 230 |
lung | 98% | 4077.63 | 569 / 578 | 29% | 14.69 | 337 / 1155 |
ovary | 100% | 14417.73 | 180 / 180 | 27% | 15.11 | 118 / 430 |
uterus | 99% | 12986.08 | 168 / 170 | 22% | 18.71 | 103 / 459 |
intestine | 87% | 4546.10 | 841 / 966 | 18% | 11.09 | 96 / 527 |
esophagus | 73% | 4567.59 | 1059 / 1445 | 28% | 21.09 | 51 / 183 |
blood vessel | 100% | 8040.82 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 5722.53 | 794 / 803 | 0% | 0 | 0 / 0 |
adipose | 98% | 5594.56 | 1183 / 1204 | 0% | 0 | 0 / 0 |
stomach | 71% | 2146.30 | 254 / 359 | 26% | 17.73 | 74 / 286 |
heart | 91% | 4943.02 | 781 / 861 | 0% | 0 | 0 / 0 |
bladder | 76% | 3271.95 | 16 / 21 | 13% | 9.03 | 66 / 504 |
pancreas | 7% | 108.04 | 23 / 328 | 80% | 58.85 | 143 / 178 |
skin | 30% | 508.25 | 544 / 1809 | 29% | 23.37 | 138 / 472 |
thymus | 23% | 346.64 | 147 / 653 | 7% | 3.90 | 43 / 605 |
tonsil | 0% | 0 | 0 / 0 | 27% | 26.76 | 12 / 45 |
eye | 0% | 0 | 0 / 0 | 4% | 1.20 | 3 / 80 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.86 | 1 / 29 |
spleen | 2% | 30.50 | 4 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 2.08 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0010044 | Biological process | response to aluminum ion |
GO_0045471 | Biological process | response to ethanol |
GO_0050665 | Biological process | hydrogen peroxide biosynthetic process |
GO_0019607 | Biological process | phenylethylamine catabolic process |
GO_0021762 | Biological process | substantia nigra development |
GO_0014063 | Biological process | negative regulation of serotonin secretion |
GO_0045964 | Biological process | positive regulation of dopamine metabolic process |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_0009636 | Biological process | response to toxic substance |
GO_0010269 | Biological process | response to selenium ion |
GO_0051412 | Biological process | response to corticosterone |
GO_0032496 | Biological process | response to lipopolysaccharide |
GO_0042420 | Biological process | dopamine catabolic process |
GO_0005739 | Cellular component | mitochondrion |
GO_0005740 | Cellular component | mitochondrial envelope |
GO_0043025 | Cellular component | neuronal cell body |
GO_0030425 | Cellular component | dendrite |
GO_0005741 | Cellular component | mitochondrial outer membrane |
GO_0050660 | Molecular function | flavin adenine dinucleotide binding |
GO_0097621 | Molecular function | monoamine oxidase activity |
GO_0009055 | Molecular function | electron transfer activity |
GO_0052595 | Molecular function | aliphatic amine oxidase activity |
GO_0008131 | Molecular function | primary amine oxidase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | MAOB |
Protein name | Amine oxidase (EC 1.4.3.-) Amine oxidase [flavin-containing] B (EC 1.4.3.21) (EC 1.4.3.4) (Monoamine oxidase type B) (MAO-B) |
Synonyms | |
Description | FUNCTION: Catalyzes the oxidative deamination of primary and some secondary amines such as neurotransmitters, and exogenous amines including the tertiary amine, neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), with concomitant reduction of oxygen to hydrogen peroxide and participates in the metabolism of neuroactive and vasoactive amines in the central nervous system and peripheral tissues . Preferentially degrades benzylamine and phenylethylamine . . |
Accessions | ENST00000378069.5 [P27338-1] P27338 Q8TBI1 |